Clinical Trial Update: Study of NMDA Antagonists and Neuropathic Pain [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating NMDA antagonists for neuropathic pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuropathic Pain

Drugs mentioned

• NMDA antagonists

Snippet

Sponsor: University Hospital, Clermont-Ferrand | Conditions: Neuropathic Pain | Phase 2 | Status: COMPLETED